THE DEAL, AT A GLANCE
From the announcementAttovia
01Who is involvedBacked by Goldman Sachs Asset Management, Deep Track CapitalFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedAttovia raised $265M Series C, announced 2026-08-07From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersAttovia's $265M Series C is an upper-percentile Healthcare & Life Sciences financing that signals available capital for late-stage antibody-based therapeutics exposure…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Attovia · Financing Record
Explore source-linked visual explanations for Attovia. Unsupported claims are withheld while source review continues.
Record 9744 · Recorded date: 2026-08-07
Explore company records →